ID: ALA3091616

Max Phase: Preclinical

Molecular Formula: C18H19NO5

Molecular Weight: 329.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1CCc1nc(C)c(O)c(C(C)=O)c1C(=O)O

Standard InChI:  InChI=1S/C18H19NO5/c1-10-17(21)15(11(2)20)16(18(22)23)13(19-10)9-8-12-6-4-5-7-14(12)24-3/h4-7,21H,8-9H2,1-3H3,(H,22,23)

Standard InChI Key:  ODRZRDKKUMTXOJ-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.35Molecular Weight (Monoisotopic): 329.1263AlogP: 2.79#Rotatable Bonds: 6
Polar Surface Area: 96.72Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.67CX Basic pKa: 3.30CX LogP: 2.32CX LogD: -0.16
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.79Np Likeness Score: 0.01

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source